The 2010 impact factor for the International Journal of Nanomedicine has been released at 4.976 (up from 2.612).
Thomas Webster, Editor-in-Chief, proudly says "Coupled with our average initial peer-review period of only 11 days, we continue to be a leader in high quality, timely publication of nanomedicine related research. To date, we have published over 474 articles (with over 1.5 million views through our open access format on our web site), making us one of the largest journals at the intersection of nanotechnology and medicine."
The JCR provides information about highly-cited, peer reviewed publications and is the source of the new Journal Impact Factors.
As Thomson Reuters quotes, "Journal Selection takes place throughout the course of a year and its goal is to identify, evaluate and select the most important and influential International and Regional journals for coverage in Thomson Reuters Web of Knowledge platform. The following year, these data are then analyzed and published in the JCR release, providing a view of how these journals are integrated, through citation, with the scholarly, multidisciplinary literature."
Dove Medical Press is a privately held publisher of 100+ open access peer-reviewed journals across the broad spectrum of science, technology and especially medicine. Dove was founded in 2003 and has offices in the United Kingdom and New Zealand, with an active presence in the USA and a network of agents in Europe, the Americas, and Southeast Asia.